|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 32.24 USD | -0.83% |
|
+13.20% | - |
| 10-19 | SpyGlass Pharma Reports Trial of Eye Implant Lowers Pressure by 37% | MT |
| 10-19 | Spyglass Pharma Announces Positive 4-Year First-In-Human Trial Results for the Bimatoprost Drug Pad-Iol System | CI |
| Market Cap | 1.08B 966M 888M 805M 1.5B 102B 1.53B 10.59B 4.25B 53.86B 4.05B 3.96B 170B | P/E 2026 * |
-12.7x | P/E 2027 * | -10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.08B 966M 888M 805M 1.5B 102B 1.53B 10.59B 4.25B 53.86B 4.05B 3.96B 170B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
95.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SGP | Delayed | |
CBOE
| SGP | Real-time |
Last Transcript: SpyGlass Pharma, Inc.
| 1 day | -0.83% | ||
| 1 week | +13.20% | ||
| 1 month | +24.00% | ||
| 3 months | +43.10% | ||
| 6 months | +40.54% |
| 1 week | 28.09 |  | 33.84 |
| 1 month | 22.8 | | 33.84 |
| Current year | 17.06 | | 33.84 |
| 1 year | 17.06 | | 33.84 |
| 3 years | 17.06 | | 33.84 |
| 5 years | 17.06 | | 33.84 |
| 10 years | 17.06 | | 33.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Mooney
CEO | Chief Executive Officer | 52 | 2021-06-30 |
Malik Kahook
PSD | President | 51 | 2018-12-31 |
| Director of Finance/CFO | 60 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Malik Kahook
CHM | Chairman | 51 | 2020-12-31 |
Ali Behbahani
BRD | Director/Board Member | 49 | 2019-04-30 |
Patrick Mooney
BRD | Director/Board Member | 52 | 2021-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/9/26 | RA Capital Management LP
| Conversion | Company | 12,352,234 | 54.8107% | |
| 2/9/26 | NEA Management Co. LLC
| Conversion | Company | 13,847,102 | 61.4439% | |
| 2/9/26 | NEA Management Co. LLC
| Conversion | Company | 13,847,102 | 61.4439% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83% | +13.20% | - | - | 1.08B | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | +0.22% | +8.11% | +47.58% | +194.99% | 39.54B | |
| Weighted average by Cap. | +0.18% | +5.46% | +47.99% | +176.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -77.96M -69.83M -64.23M -58.2M -109M -7.4B -111M -766M -307M -3.89B -293M -286M -12.28B | -103M -92.65M -85.22M -77.22M -144M -9.82B -147M -1.02B -408M -5.17B -388M -380M -16.29B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$32.24 | -0.83% | 94,146 |
| 26-10-29 | US$32.51 | -1.07% | 125,363 |
| 26-10-28 | US$32.86 | +6.34% | 211,717 |
| 26-10-27 | US$30.90 | +3.31% | 69,339 |
| 26-10-26 | US$29.91 | +5.02% | 89,403 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SGP Stock
Select your edition
All financial news and data tailored to specific country editions
